Although overshadowed by the FDA’s decision to deny Premarket Tobacco Applications (PMTAs) that don’t include “product-specific” evidence addressing flavored vaping products’ “risk posed to youth,” the agency is continuing its purge of products sold by small vape manufacturers without first submitting PMTAs.
Products that were not submitted for review by the Sept. 9, 2020 deadline were supposed to have been removed immediately from the market. The difficult and expensive PMTA process discouraged many small manufacturers from attempting to comply, and many continued to sell products after the deadline.
The FDA Center for Tobacco Products announced Thursday that 29 warning letters were sent in August to vaping manufacturers and sellers, ordering them to remove products from the market or face enforcement actions. According to the agency, these companies have more than 268,000 products registered with the FDA.
Two of the letters sent in August went to manufacturers that submitted PMTAs the FDA refused to accept, and another went to a company that filed PMTAs for some products but not others.
Since our last update on June 4, the FDA has issued 47 warning letters (including the August letters), making a total of 169 so far this year.
Because of declining cigarette sales, state governments in the U.S. and countries around the world are looking to vapor products as a new source of tax revenue.
A list of vaping product flavor bans and online sales bans in the United States, and sales and possession bans in other countries.
A closer look at PouchPoint, an online nicotine pouch store offering competitive pricing, wide selection, and a smooth shopping experience.
A practical, data-driven breakdown of where the vape market is heading—and how to position your business ahead of regulatory and category shifts.
